1. Negative roles of B7-H3 and B7-H4 in the microenvironment of cervical cancer
   Sai Han et al, 2018, Experimental Cell Research CrossRef
2. B7-H4, a promising target for immunotherapy
   Jia-Yu Wang et al, 2020, Cellular Immunology CrossRef
3. Combined detection of CA19-9 and B7-H4 in the diagnosis and prognosis of pancreatic cancer
   Xiangming Xu et al, 2019, Cancer Biomarkers CrossRef
4. B7-Homolog 4 Promotes Epithelial‐Mesenchymal Transition and Invasion of Bladder Cancer Cells via Activation of Nuclear Factor-κB
   Haoran Wu et al, 2018, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
5. Immune Regulatory Network in Cervical Cancer Development: The Expanding Role of Innate Immunity Mechanisms
   Olga Kurmyshkina et al, 2018, Cervical Cancer - Screening, Treatment and Prevention - Universal Protocols for Ultimate Control CrossRef
6. Silencing of B7H4 Represses the Development of Oral Squamous Cell Carcinoma Through Promotion of M1 Macrophage Polarization
   Jingwen Chi et al, 2022, Journal of Oral and Maxillofacial Surgery CrossRef
7. B7-H4 Expression in Precancerous Lesions of the Uterine Cervix
   Qianqian Zhang et al, 2021, BioMed Research International CrossRef
8. Association between B7‑H1 and cervical cancer: B7‑H1 impairs the immune response in human cervical cancer cells
   Jianying Tao et al, 2017, Experimental and Therapeutic Medicine CrossRef
9. The loss of B7-H4 expression in breast cancer cells escaping from T cell cytotoxicity contributes to epithelial-to-mesenchymal transition
   Linlin Zhou et al, 2023, Breast Cancer Research CrossRef